Correspondingly, several other studies have reported an increased expression of hsa-miR-200b-3p in PCa compared with that in benign prostatic hyperplasias [25], as well as a positive correlation with TIMP4, which is an inhibitor of MMP2 [26,27]. This evidence concerns the gene TIMP4 and benign prostatic hyperplasia.